Sintx Technologies, Inc.

SINTX Technologies is a U.S.-based advanced ceramics company focused on silicon nitride materials and components for biomedical and other technical applications. Its business combines materials research, manufacturing, and commercialization of ceramic products used in medical devices, with additional activity in coatings, aerospace-related materials, toll processing, and government-funded work.

−1 021,8 %

45,3 %

−1 018,1 %

−64,7 %

1.51

1.29

— Sintx Technologies, Inc.
%
Biomedical silicon nitride products45% Medical-grade ceramic materials and components used in implant and device applications.
Aerospace coatings and materials20% Advanced ceramic coatings, materials, and related components for aerospace uses.
Toll processing and manufacturing services20% Contract processing and manufacturing work performed for third-party customers.
Government contracts and grants15% Revenue tied to government-funded research, development, and contract work.

SINTX sells to medical device customers, industrial and aerospace customers, and government counterparties that fund...

  • Medical device OEMsprimary

    Buy silicon nitride materials and components for implant and fusion-device applications because of biocompatibility and wear properties.

  • Aerospace customerssecondary

    Buy coatings, materials, and components for technical applications where ceramic performance matters.

  • Government agenciessecondary

    Fund contract and grant work tied to research, development, and technical programs.

  • Third-party manufacturerssecondary

    Use toll processing and manufacturing support to access advanced ceramic capabilities without building them in-house.

SINTX is headquartered in the United States and serves customers across multiple regions through its biomedical and...

  • •Headquartered and operated from the United States
  • •Medical implant use has extended into Europe, South America, and Asia
  • •U.S. market is important for medical device and government work
  • •International adoption depends on local regulatory and OEM qualification
  • •Aerospace and industrial customers may be served through U.S. operations

SINTX’s strategy is to leverage its silicon nitride and advanced ceramics expertise across biomedical, aerospace, and...

01
Commercialize silicon nitride in more device categoriesmedium-term

Broader adoption increases the addressable market for the company’s core material platform.

02
Secure third-party manufacturing and toll processing workshort-term

These relationships can convert technical capability into recurring product and service revenue.

03
Develop non-medical advanced ceramics applicationsmedium-term

Diversification can reduce dependence on a single end market and expand customer reach.

SINTX faces the typical risks of a development-stage materials company, including dependence on customer adoption,...

high

Need for additional capital

The company states it will require substantial future capital to fund development and commercialization.

Scope
Operating runway and product development
Materiality
high
high

Commercial adoption risk

Revenue depends on customers qualifying and adopting silicon nitride and related products.

Scope
Medical device and aerospace sales
Materiality
high
high

Regulatory and clinical validation risk

Biomedical products must clear technical, clinical, and regulatory hurdles before broad use.

Scope
Implant and fusion-device applications
Materiality
high
medium

Revenue concentration and volatility

Grant and contract revenue can fluctuate materially with award timing and project disposition.

Scope
Government-funded work and contract revenue
Materiality
medium
Revenue recognition timing
Quarterly revenue comparability
Grant and contract revenue
Revenue volatility
Derivative liabilities
Net income volatility
Asset impairment and collectability
Balance sheet and earnings estimates

Silexion Therapeutics Corp

SLXN · Biological Products, (No Diagnostic Substances)

SYNTEC OPTICS HOLDINGS, INC.

OPTX · Optical Instruments & Lenses

Tronox Holdings plc

TROX · Industrial Inorganic Chemicals

SIGA TECHNOLOGIES INC

SIGA · Pharmaceutical Preparations

BiomX Inc.

PHGE · Biological Products, (No Diagnostic Substances)

SinterCast

SINT.ST · Industrials

: 29/04/2026